(NASDAQ: JAN) JANONE INC. shares popped up 40% on news this morning. Shares are surging at $3.48 as traders have more than 30,000 trades on heavy volume.

June 7, 2022

LAS VEGAS, June 7, 2022 /PRNewswire/ — JanOne Inc. (Nasdaq:JAN), a company that focuses on the development of drugs with non-addictive, pain-relieving properties, announced today that a patent was issued that covers a method of improving nerve function using JAN101. JAN101 (formerly known as TV1001SR), is a potential treatment for peripheral artery disease (PAD), a vascular disease that affects more than 8.5 million people in the U.S. and more than 60 million people worldwide.

https://ir.janone.com/news-events/press-releases/detail/44/janone-inc-announces-the-issuance-of-u-s-patent-covering

Pages: 1 2

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.